Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|November 30, 2017
Investigation of adult immunodeficiency and indications for immunoglobulin replacement therapyS Ress
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|November 5, 1977
Clofibrate-induced complications in renal disease: a case reportN Pokroy, S Ress, M C Gregory
The American Journal of Medicine|June 1, 1995
Extensive bone marrow necrosis associated with antiphospholipid antibodiesS Bulvik, I Aronson, S Ress, et al.
Novartis Foundation Symposium|February 9, 1999
Recombinant interleukin 2 adjunctive therapy in multidrug-resistant tuberculosisB Johnson, L G Bekker, S Ress, et al.
Human Immunology|June 1, 1985
Inhibition of anti-class I cytotoxicity by anti-class II monoclonal antibodies (MoAb). I. Blocking of bulk non-DR and non-DQ-directed cytotoxic T cells by MoAb against DR, DQ, and DPG Strassmann, S Ress, A Anichini, et al.
Human Immunology|June 1, 1985
Inhibition of anti-class I cytotoxicity by anti-class II monoclonal antibodies (MoAb). II. Blocking of anti-class I CTL clones by anti-DR MoAbA Anichini, S Ress, G Strassmann, et al.
Infection and Immunity|May 29, 1998
Differential gene expression in response to adjunctive recombinant human interleukin-2 immunotherapy in multidrug-resistant tuberculosis patientsB J Johnson, I Estrada, Z Shen, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 1, 1997
rhuIL-2 adjunctive therapy in multidrug resistant tuberculosis: a comparison of two treatment regimens and placeboB J Johnson, L G Bekker, R Rickman, et al.
Pageof 1